Merck, Darmstadt Germany, is acquiring Natrix Separations Inc, Burlington ON, a provider of hydrogel membrane products used to eliminate impurities during bioprocessing and accelerate the production of monoclonal antibodies and vaccines. Natrix markets both an anion exchange membrane and cation exchange membrane and is developing additional products to enable a fully single-use, full-scale biological purification…
Organization: Natrix Separations Inc
Natrix raises $19 million for commercialization
Burlington ON-based Natrix Separations Inc has closed a $19-million, series B financing to support commercialization of its separation products and complete construction of its ISO9001-compliant manufacturing facility. DE Shaw Venture Capital, Cupertino CA, is the lead investors with participation by BDC Venture Capital and Canadian Medical Discovery Funds (now part of Jovian Capital Corp). The…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...